Renishaw plc stock (GB0007365546): Record revenue and raised guidance in FY2026

Renishaw plc has reported record annual revenue and raised its full?year FY2026 guidance after a strong third quarter, drawing attention from US investors in the precision?measurement and industrial?technology space.

Renishaw plc has reported record annual revenue of £713.0 million and a 3.8% increase in adjusted profit before tax for the year ended 30 June 2025, according to a company?sourced report published on 5 May 2026.DirectorsTalk Interviews as of 05/05/2026 The engineering technology group also highlighted sustained growth over the first nine months of its current financial year, reinforcing its position in the global precision?measurement and manufacturing?systems market.

Building on that momentum, Renishaw has raised its full?year revenue guidance for the financial year ending 30 June 2026 to a range of £775 million to £805 million, up from an earlier band of £740 million to £780 million, as reported by AJ Bell on 24 April 2026.YouInvest / AJ Bell as of 24/04/2026 The company continues to back its previously communicated outlook, indicating confidence in demand for its measurement and production systems despite broader macroeconomic headwinds.

As of: 09.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Renishaw plc
• Sector/industry: Technology / Scientific & Technical Instruments
• Headquarters/country: United Kingdom
• Core markets: Global industrial, healthcare and analytical?instruments markets
• Key revenue drivers: Precision measurement systems, manufacturing technologies, analytical instruments and medical devices
• Home exchange/listing venue: London Stock Exchange (LSE: RSW)
• Trading currency: GBP

Renishaw plc: core business model

Renishaw plc is an engineering technology group that designs, manufactures, distributes and services precision measurement and motion?control systems for industrial and scientific applications.Renishaw corporate overview as of 09/05/2026 The company operates across two main reporting segments: Manufacturing technologies, which includes machine?tool and coordinate?measuring?machine (CMM) products, and Analytical instruments and medical devices, which covers spectroscopy, healthcare and neurology?related technologies.

Renishaw’s business model centers on high?value, low?volume engineered products that require long?term customer relationships and after?sales service, including calibration, maintenance and software support.Morningstar company profile as of 09/05/2026 This structure supports recurring revenue streams and relatively high gross margins, although it also exposes the group to cyclicality in industrial capital?expenditure cycles and global manufacturing demand.

Main revenue and product drivers for Renishaw plc

Renishaw’s primary revenue drivers are its industrial?measurement systems, including encoders, probes and calibration equipment used in machine tools, coordinate?measuring machines and automated production lines.ZoomInfo overview as of 09/05/2026 These products are deployed in sectors such as automotive, aerospace, energy and general engineering, where accuracy and repeatability are critical for quality control and process optimization.

Within the Analytical instruments and medical?devices segment, Renishaw focuses on Raman spectroscopy systems and neurosurgical technologies, which serve pharmaceutical, materials?science and healthcare customers.Renishaw product overview as of 09/05/2026 Growth in this area is supported by increasing demand for advanced analytical tools in research and development, as well as by the expansion of minimally invasive surgical procedures that rely on precision?positioning systems.

Why Renishaw plc matters for US investors

For US investors, Renishaw offers exposure to global industrial automation and advanced?manufacturing trends without direct listing on a US exchange.Investing.com overview as of 09/05/2026 The company’s products are used in North American factories and research labs, giving US?based portfolios indirect access to the growth of precision?measurement technologies in key sectors such as aerospace, automotive and medical devices.

Renishaw’s relatively high valuation multiples, including a trailing price?to?earnings ratio above 45 and a price?to?sales ratio around 3.5, reflect its niche positioning and strong brand in high?precision instrumentation.Morningstar metrics as of 09/05/2026 For US investors comfortable with foreign?exchange risk and London?listed equities, the stock can serve as a satellite holding in a diversified technology or industrials allocation.

Conclusion

Renishaw plc has delivered record annual revenue and raised its full?year FY2026 guidance, signaling continued strength in its core measurement and manufacturing?technology businesses.DirectorsTalk Interviews as of 05/05/2026YouInvest / AJ Bell as of 24/04/2026 The company’s focus on high?precision, engineered products supports attractive margins but also ties performance closely to industrial?capex cycles and global manufacturing activity.

For US investors, Renishaw offers a way to gain exposure to advanced?measurement and automation technologies through a London?listed stock, with associated currency and liquidity considerations.Investing.com overview as of 09/05/2026 The recent guidance upgrade and record revenue provide a positive near?term backdrop, yet investors should weigh this against the stock’s elevated valuation and sector?specific risks before making any decisions.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.